147 related articles for article (PubMed ID: 32370518)
1. FAMILIAL HYPERCHOLESTEROLAEMIA - A DIAGNOSIS THAT EVERY PLASTIC SURGEON CAN EXPERIENCE.
Šatný M; Vaclová M; Vráblík M
Acta Chir Plast; 2020; 60(2-4):54-58. PubMed ID: 32370518
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of Familial Hypercholesterolaemia on First Sight? The Role of the Ophthalmologist in Identifying Patients with Familial Hypercholesterolaemia.
Altschmiedová T; Vaclová M; Vráblík M
Cesk Slov Oftalmol; 2019; 74(4):127-131. PubMed ID: 30913887
[TBL] [Abstract][Full Text] [Related]
3. How to implement clinical guidelines to optimise familial hypercholesterolaemia diagnosis and treatment.
Farnier M; Civeira F; Descamps O;
Atheroscler Suppl; 2017 Apr; 26():25-35. PubMed ID: 28434482
[TBL] [Abstract][Full Text] [Related]
4. Improving the detection of familial hypercholesterolaemia.
Lan NSR; Martin AC; Brett T; Watts GF; Bell DA
Pathology; 2019 Feb; 51(2):213-221. PubMed ID: 30579649
[TBL] [Abstract][Full Text] [Related]
5. Management of patients with familial hypercholesterolaemia.
Reiner Ž
Nat Rev Cardiol; 2015 Oct; 12(10):565-75. PubMed ID: 26076948
[TBL] [Abstract][Full Text] [Related]
6. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
7. Severe xanthomatosis in heterozygous familial hypercholesterolemia.
Aljenedil S; Ruel I; Watters K; Genest J
J Clin Lipidol; 2018; 12(4):872-877. PubMed ID: 29778561
[TBL] [Abstract][Full Text] [Related]
8. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.
Kazi DS; Moran AE; Coxson PG; Penko J; Ollendorf DA; Pearson SD; Tice JA; Guzman D; Bibbins-Domingo K
JAMA; 2016 Aug; 316(7):743-53. PubMed ID: 27533159
[TBL] [Abstract][Full Text] [Related]
10. Progress in the care of familial hypercholesterolaemia: 2016.
Bell DA; Watts GF
Med J Aust; 2016 Sep; 205(5):232-6. PubMed ID: 27581271
[TBL] [Abstract][Full Text] [Related]
11. Low density lipoprotein--receptor (LDL-R) gene mutations among Filipinos with familial hypercholesterolemia.
Punzalan FE; Sy RG; Santos RS; Cutiongco EM; Gosiengfiao S; Fadriguilan E; George P; Laurie A
J Atheroscler Thromb; 2005; 12(5):276-83. PubMed ID: 16205024
[TBL] [Abstract][Full Text] [Related]
12. New Horizons in the Pathogenesis, Pathophysiology and Treatment of Familial Hypercholesterolaemia.
Viigimaa M; Heinsar S; Lovic D; Katsimardou A; Piperidou A; Duishvili D
Curr Pharm Des; 2018; 24(31):3599-3604. PubMed ID: 30306860
[TBL] [Abstract][Full Text] [Related]
13. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Lozano P; Henrikson NB; Dunn J; Morrison CC; Nguyen M; Blasi PR; Anderson ML; Whitlock EP
JAMA; 2016 Aug; 316(6):645-55. PubMed ID: 27532919
[TBL] [Abstract][Full Text] [Related]
14. A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).
Descamps OS; Van Caenegem O; Hermans MP; Balligand JL; Beauloye C; Bondue A; Carlier S; Castermans E; Chenot F; Claeys M; De Block C; de Leener A; De Meester A; Demeure F; De Raedt H; Desmet W; Elegeert I; Guillaume M; Hoffer E; Kacenelenbogen R; Lancellotti P; Langlois M; Leone A; Mertens A; Paquot N; Vanakker O; Vanoverschelde JL; Verhaegen A; Vermeersch P; Wallemacq C; Rietzschel E;
Atherosclerosis; 2018 Oct; 277():369-376. PubMed ID: 30270073
[TBL] [Abstract][Full Text] [Related]
15. [Severe hypercholesterolaemia--when to use the proprotein convertase subtilisin-kexin type 9 protease inhibitors (PCSK9 inhibitors)? Polish Society of Cardiology experts' group statement].
Cybulska B; Gaciong Z; Hoffman P; Jankowski P; Kłosiewicz-Latoszek L; Kaźmierczak J; Mitręga K; Opolski G; Pająk A; Ponikowski P; Rynkiewicz A; Stępińska J; Średniawa B; Kalarus Z
Kardiol Pol; 2016; 74(4):394-8. PubMed ID: 27098076
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017.
Harada-Shiba M; Arai H; Ishigaki Y; Ishibashi S; Okamura T; Ogura M; Dobashi K; Nohara A; Bujo H; Miyauchi K; Yamashita S; Yokote K;
J Atheroscler Thromb; 2018 Aug; 25(8):751-770. PubMed ID: 29877295
[TBL] [Abstract][Full Text] [Related]
17. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.
Singh A; Gupta A; Collins BL; Qamar A; Monda KL; Biery D; Lopez JAG; de Ferranti SD; Plutzky J; Cannon CP; Januzzi JL; Di Carli MF; Nasir K; Bhatt DL; Blankstein R
J Am Coll Cardiol; 2019 May; 73(19):2439-2450. PubMed ID: 31097165
[TBL] [Abstract][Full Text] [Related]
18. 2017 Taiwan lipid guidelines for high risk patients.
Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
[TBL] [Abstract][Full Text] [Related]
19. Screening for familial hypercholesterolaemia.
Bender R; Bell DA; Hooper AJ; Edwards G; van Bockxmeer FM; Watts GF; Burnett JR
Pathology; 2012 Feb; 44(2):122-8. PubMed ID: 22228254
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
